Accu-Chek FastClix Diabetic Supply Kit
$80.00
18
Items sold in last 3 minutes
1000 in stock
🔥Buy 3, Get 1 Free – Mix & Match Any Products!🔥
Estimated delivery dates: Jul 31, 2026 - Aug 1, 2026
16
People watching this product now!
Description
Accu-Chek FastClix Blood Sugar Test Kit
When you use the FastClix system from Accu-Chek, testing your blood is made simpler and easier than ever.
Checking your glucose level is an essential part of managing your diabetes. The Accu-Check FastClix lancing device and lancets make this easier than ever. Precision-guided technology minimizes pain, and customizable depth settings allow you to get the right amount of blood the first time.
FastClix Supply Kit Includes:
- 300 x Accu-Chek Guide Test Strips
- 306 x FastClix Lancets
- 2 x Guide Control Solutions (2.5ml of level 1 and 2.5ml of level 2)
- 300 x Alcohol Pads
- 1 x Self-Test Diary Log Book
Accu-Chek FastClix Kit Features:
- This three-month supply kit is designed to help you manage your diabetes more efficiently and provide better control of your health.
- Reduce the pain and hassle of testing your blood sugar with convenient pre-set lancets. Load the drum into the FastClix lancing device (not included) to collect a small blood sample without handling needles.
- For more convenient testing, the unique FastClix design allows a tiny drop of blood to be placed anywhere along the end of the strip.
- Patented spill-resistant SmartPack dispenses one strip at a time.
- Ensure meter accuracy by doing routine checks with the control solution as it contains a known amount of glucose.
FastClix Lancing Device System Features:
- The only 1-click lancing system with a drum
- 11 customizable depth settings
- Precision guided technology
- Thin-gauge, bevel-cut lancets
Additional information
| Weight | 0.68 lbs |
|---|
Reviews (0)
Be the first to review “Accu-Chek FastClix Diabetic Supply Kit” Cancel reply
Related products
Select options
This product has multiple variants. The options may be chosen on the product page

Reviews
There are no reviews yet.